FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
Lack of communication between dermatologists and histopathologists in real-life settings: a survey of the Italian Association of Hospital Dermatologists (ADOI) Dermatologist-to-histopathologist communication
563PDF: 414HTML: 50 -
23 | Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study Maria Chiara Sergi*1, Teresa Amaral*2, Piotr Rutkowski*3, Marie-Lena Rasch2, Naima Benannoune4, Patricio Serra5, Maria Grazia Vitale6, Diana Giannarelli7, Ana Maria Arance8, Eva Munoz Couselo9, Bart Neyns10, Iris Dirven11, Marco Tucci12, Michele Guida13, Francesco Spagnolo14, Ernesto Rossi15, Paola Queirolo16, Pietro Quaglino17, Roberta Depenni18, Joanna Placzke3, Anna Maria Di Giacomo19, Michele Del Vecchio20, Alice Indini20, Ines Pires da Silva21, Alexander M. Menzies22, Angela Hong23, Paul Lorigan5, Caroline Robert24, Georgina V. Long22, Paolo A. Ascierto6, Mario Mandalà25 | 1Unit of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Asl BT, Barletta, Italy; 2Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. 3Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 4Gustave Roussy Cancer Campus, Villejuif, France. 5The University of Manchester, Manchester, UK. 6Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy; 7Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 8Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain; 9Department of medical oncology. Vall d"Hebron Hospital, Barcelona, Spain & Vall d’Hebron Institute of oncology, VHIO. Barcelona, Spain; 10Department of Medical Oncology, UZ Brussel, Brussels, Belgium. 11Department of medical oncology, Vrije Universiteit Brussel, VUB, Universitair Ziekenhuis Brussel, Brussels, Belgium; 12Medical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, 70124 Bari, Italy. 13Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori "Giovanni Paolo II," Bari, Italy. 14IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; 15Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 16IEO European Institute of Oncology, IRCCS, Milan, Italy. 17Department of Dermatology, University of Turin, Turin, Italy. 18University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy; 19Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. 20Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 21Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia; 22Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia; 23Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Australia; Department of Radiation Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; 24Gustave Roussy and Paris-Saclay University, Villejuif, France; 25Unit of Medical Oncology, University of Perugia, Perugia, Italy. § on behalf of the Italian Melanoma Intergroup - IMI.
397 -
23 | CURRENT CHALLENGES IN MODERATE ATOPIC DERMATITIS: AN ITALIAN DELPHI CONSENSUS I. Marzona1, A. Costanzo2, A. Campanati3, M. Esposito4, S. M. Ferrucci5, G. Girolomoni6, C. Patruno7, E. Pezzolo8, S. Ribero9, M. Rossi10, L. Stingeni11, L. Politi1, M. Napolitano12 | 1Helaglobe Srl; 2Dermatology Unit, IRCCS Humanitas Research Hospital Dermatology, Italy; 3Dermatological Clinic, Università Politecnica delle Marche, Italy; 4Biotechnological and Clinical Sciences University of L’Aquila, Italy; 5IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Italy; 6Section of Dermatology, University of Verona, Italy; 7Medicine and Health Sciences, Molise University, Italy; 8Department of Dermatology, San Bortolo Hospital, Italy; 9Dermatology Clinic, University of Turin, Italy; 10Dermatology Unit, University of Brescia, Italy; 11Dermatology Section, University of Perugia, Italy; 12Section of Dermatology, University of Naples, Italy
82PDF: 19 -
Application of ChatGPT as a content generation tool in continuing medical education: acne as a test topic
1361PDF: 735SUPPLEMENTARY MATERIAL: 196HTML: 28 -
29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY F. Pavan1, F. Cassalia2, S. Giordano3, A. Gelmetti4, L. Ventura5, F. Caroppo2, A. Bassi6, F. Martorana7, R. Balestri8, A. Guglielmo9, F. Ambrogio10, A. Bonvicino3, I. Neri4, P. Quaglino3, A. Belloni Fortina11 | 1Pediatrics Unit, Department of Women’s and Child’s Health (SDB), University of Padua, Italy; 2Dermatology Unit, Department of Medicine (DIMED), University of Padua, Italy; 3Department of Medical Sciences, Section of Dermatology, University of Turin, Italy; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Italy; 5Department of Statistical Science, University of Padua, Italy; 6Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; 7Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II; 8Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS, Trento, Italy; 9Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; 10Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Italy; 11Pediatric Dermatology Department of Women’s and Child’s Health (SDB), University of Padua, Italy
79PDF: 16 -
-
68 | FULMINANT SJS/TEN-LIKE PEMPHIGUS VULGARIS WITH HIGH ANTI-DSG1 TITERS AND CMV REACTIVATION: AN IMMUNOLOGICAL CHALLENGE R. Daher2, A. Verdelli1, L. Sanna2, V. Corti2, A. Magnatta2, S. Landini2, M. Donati3, I. Bonanni1, A. Corrà4, V. Ruffo Di Calabria5, E. Mariotti6, C. Della Bella7, L. Giovannoni8, M. D'Elios7, A. Moggi Pignone9, M. Caproni1 | (1)Rare Dermatological Diseases Unit, Department of Health Sciences, University of Florence, Florence, Italy; (2)Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy; (3)Dermatology Department, University of Modena and Reggio Emilia, Modena, Italy; (4)Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; (5)SSD Dermatologia, Cardinal Massaia Hospital, Asti, Italy; (6)Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; (7)Department of Molecular and Developmental Medicine, University of Siena, Italy; (8)UOC Ricerca e Sviluppo Clinical Practice, AOU Careggi, Florence, Italy; (9)Department of Experimental and Clinical Medicine, Division of Internal Medicine, University of Florence, Italy
81PDF: 15
